Myriad to Announce Fiscal Third Quarter 2015 Financial Results on May 5, 2015
April 22 2015 - 7:05AM
Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will
issue financial results for the fiscal third quarter 2015 and
provide a business update following the close of market on Tuesday,
May 5, 2015.
The Company also will host a conference call at 4:30 p.m. ET on
May 5, 2015 to discuss the financial results. Participating on the
call will be Peter Meldrum, president and CEO; Mark Capone,
president of Myriad Genetic Laboratories, Inc., and Bryan Riggsbee,
chief financial officer.
To listen to the call, interested parties in the United States
may dial 800-732-8470 or +1 212-231-2910 for international callers.
All callers will be asked to reference reservation number
21766620.
The conference call also will be available through a live
webcast at www.myriad.com. A replay of the call will be available
two hours after the end of the call for seven days and may be
accessed by dialing 800-633-8284 within the United States or +1
402-977-9140 for international callers and entering reservation
number 21766620.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic company
dedicated to making a difference in patients' lives through the
discovery and commercialization of transformative tests to assess a
person's risk of developing disease, guide treatment decisions and
assess risk of disease progression and recurrence. Myriad is
focused on strategic directives to grow existing markets, diversify
through the introduction of new products, including companion
diagnostics, as well as to expand internationally. For more
information on how Myriad is making a difference, please visit the
Company's website: www.myriad.com.
Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris
AP, myPath, myRisk, myRisk Hereditary Cancer, myChoice, myPlan Lung
Cancer, BRACAnalysis CDx, HRD, Vectra and Prolaris are trademarks
or registered trademarks of Myriad Genetics, Inc. in the United
States and foreign countries. MYGN-F, MYGN-G
CONTACT: Media Contact:
Ron Rogers
(801) 584-3065
rrogers@myriad.com
Investor Contact:
Scott Gleason
(801) 584-1143
sgleason@myriad.com
Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Myriad Genetics (NASDAQ:MYGN)
Historical Stock Chart
From Apr 2023 to Apr 2024